SLC7A3
Cationic amino acid transporter 3
Also known as: ATRC3, CAT-3, CTR3_HUMAN, FLJ14541
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WY07
- Gene
- SLC7A3
- Ensembl
- ENSG00000165349
- Chromosome
- X
- Canonical length
- 619 aa
- Protein class
- FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of the solute carrier family 7. The encoded protein is a sodium-independent cationic amino acid transporter. Alternate splicing results in multiple transcripts that encoded the same protein.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
619 residues, UniProt reviewed canonical sequence.
>Q8WY07|SLC7A3
1 MPWQAFRRFG QKLVRRRTLE SGMAETRLAR CLSTLDLVAL GVGSTLGAGV YVLAGEVAKD
61 KAGPSIVICF LVAALSSVLA GLCYAEFGAR VPRSGSAYLY SYVTVGELWA FTTGWNLILS
121 YVIGTASVAR AWSSAFDNLI GNHISKTLQG SIALHVPHVL AEYPDFFALG LVLLLTGLLA
181 LGASESALVT KVFTGVNLLV LGFVMISGFV KGDVHNWKLT EEDYELAMAE LNDTYSLGPL
241 GSGGFVPFGF EGILRGAATC FYAFVGFDCI ATTGEEAQNP QRSIPMGIVI SLSVCFLAYF
301 AVSSALTLMM PYYQLQPESP LPEAFLYIGW APARYVVAVG SLCALSTSLL GSMFPMPRVI
361 YAMAEDGLLF RVLARIHTGT RTPIIATVVS GIIAAFMAFL FKLTDLVDLM SIGTLLAYSL
421 VSICVLILRY QPDQETKTGE EVELQEEAIT TESEKLTLWG LFFPLNSIPT PLSGQIVYVC
481 SSLLAVLLTA LCLVLAQWSV PLLSGDLLWT AVVVLLLLLI IGIIVVIWRQ PQSSTPLHFK
541 VPALPLLPLM SIFVNIYLMM QMTAGTWARF GVWMLIGFAI YFGYGIQHSL EEIKSNQPSR
601 KSRAKTVDLD PGTLYVHSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC7A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 14
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- thymus: 18 nTPM
- prostate: 5.4 nTPM
- seminal vesicle: 5.1 nTPM
- endometrium: 4.5 nTPM
- cervix: 3.1 nTPM
- hypothalamus: 3 nTPM
Single-cell type
- medullary thymic epithelial cells: 19 nCPM
- early spermatids: 8.3 nCPM
- late primary spermatocytes: 7.5 nCPM
- other brain neurons: 4.9 nCPM
- epididymal basal cells: 4 nCPM
- late spermatids: 3.1 nCPM
Immune cell
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 12 nTPM
- basal ganglia: 8.5 nTPM
- hypothalamus: 7.6 nTPM
- pons: 4.6 nTPM
- midbrain: 4 nTPM
- amygdala: 2.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.9
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amino acid transport
- L-arginine import across plasma membrane
- transport across blood-brain barrier
- L-lysine import across plasma membrane
- L-ornithine import across plasma membrane
Molecular functions
- amino acid transmembrane transporter activity
- L-arginine transmembrane transporter activity
- L-lysine transmembrane transporter activity
- L-ornithine transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC7A3 as an antibody target. Whether an autoantibody or antibody against SLC7A3 could matter depends on whether native SLC7A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC7A3 is annotated at the cell surface, where native SLC7A3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC7A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...